Nadine Krüger
German Primate Center(DE)Humboldt-Universität zu Berlin(DE)Johnson & Johnson (Germany)(DE)Institute of Virology of the Slovak Academy of Sciences(SK)Freie Universität Berlin(DE)Charité - Universitätsmedizin Berlin(DE)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Virology and Viral Diseases, Computational Drug Discovery Methods, SARS-CoV-2 detection and testing
Most-Cited Works
- → SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor(2020)21,183 cited
- → SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies(2021)1,040 cited
- → The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic(2021)948 cited
- → The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells(2020)757 cited
- → Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2(2020)504 cited
- → Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity(2021)391 cited